Insider Buying: Huntsworth plc (HNT) Insider Acquires 2,420 Shares of Stock
Huntsworth plc (LON:HNT) insider Neil Jones purchased 2,420 shares of the firm’s stock in a transaction dated Monday, November 12th. The shares were bought at an average cost of GBX 112 ($1.46) per share, with a total value of £2,710.40 ($3,541.62).
Shares of HNT stock traded up GBX 4 ($0.05) during mid-day trading on Monday, reaching GBX 114.50 ($1.50). 72,058 shares of the company were exchanged, compared to its average volume of 1,010,000. Huntsworth plc has a fifty-two week low of GBX 40 ($0.52) and a fifty-two week high of GBX 95 ($1.24).
A number of analysts have recently weighed in on HNT shares. Peel Hunt downgraded shares of Huntsworth to an “add” rating and raised their price target for the stock from GBX 115 ($1.50) to GBX 140 ($1.83) in a research report on Wednesday, July 18th. Numis Securities reissued a “buy” rating on shares of Huntsworth in a research report on Friday, September 28th. Finally, Berenberg Bank raised their price target on shares of Huntsworth from GBX 135 ($1.76) to GBX 150 ($1.96) and gave the stock a “buy” rating in a research report on Wednesday, August 15th.
Huntsworth plc operates as a healthcare communications and public relations company in the United States, United Kingdom, rest of Europe, Asia, and the Middle East and Africa. It operates through four divisions: Huntsworth Health, Red Consultancy, Grayling, and Citigate Dewe Rogerson (CDR). The Huntsworth Health division offers an integrated suite of communications services for the science, health, and wellbeing industries.
Featured Story: Swap
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.